Expert Guidance on the Evolving Therapeutic Landscape for HER2-Positive Early-Stage Breast Cancer

Review the latest clinical data and expert guidance on management of HER2-positive early-stage breast cancer, including how to assess risk and plan (neo)adjuvant therapy; treat lower- vs higher-risk disease; and optimally manage adverse events associated with HER2-targeted therapy.
Lee Schwartzberg, MD, FACP
Format: Microsoft PowerPoint (.ppt)
File Size: 1.22 MB
Released: June 30, 2020


Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by educational grants from
Puma Biotechnology, Inc.
Seattle Genetics

Related Content

Gain key clinical insights quickly with this short slideset from Clinical Care Options (CCO) on HER2 testing in metastatic breast cancer

Mark D. Pegram, MD Michael F. Press, MD, PhD Released: July 30, 2020

From Clinical Care Options (CCO), download this PDF summarizing HER2, HER3, and TROP2 testing and targeted therapeutics

Mark D. Pegram, MD Michael F. Press, MD, PhD Released: July 30, 2020

In this slideset from Clinical Care Options (CCO), experts provide insights on HER2 testing and resulting implications for treatment in breast cancer

Mark D. Pegram, MD Michael F. Press, MD, PhD Released: July 30, 2020

A living slideset on optimal management of breast cancer during the COVID-19 pandemic that will be updated as the situation evolves and new data emerge

Harold J. Burstein, MD, PhD Hope S. Rugo, MD Released: July 28, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?